Liquidation Sale Cynomolgus Msln/mesothelin Protein (msl-cm281) Collection [ASfydzpv]

Cynomolgus MSLN/Mesothelin Protein

Introducing the Liquidation Sale Cynomolgus Msln/mesothelin Protein (msl-cm281) Collection [ASfydzpv], a high-quality, research-grade protein designed for advanced scientific and medical applications. This protein is derived from cynomolgus monkeys, offering a reliable source for researchers and scientists in various fields. The MSLN/Mesothelin Protein is known for its critical role in cancer research, particularly in mesothelioma and ovarian cancer studies. With its exceptional purity and stability, it ensures accurate and consistent results in your experiments.

• High Purity: Our protein is rigorously tested to ensure a purity level of over 95%, guaranteeing reliable results.
• Stability: Formulated to maintain stability during storage and transport, making it convenient for researchers.

Product Specifications and Properties

The Liquidation Sale Cynomolgus Msln/mesothelin Protein (msl-cm281) Collection [ASfydzpv] is available in lyophilized powder form, making it easy to reconstitute and use. It is suitable for various applications, including immunohistochemistry, flow cytometry, and ELISA. The protein is produced using state-of-the-art technology, ensuring its high quality and consistency. Key specifications include:

• Source: Cynomolgus Monkey
• Form: Lyophilized Powder
• Applications: Immunohistochemistry, Flow Cytometry, ELISA

Practical Applications and Benefits

The Liquidation Sale Cynomolgus Msln/mesothelin Protein (msl-cm281) Collection [ASfydzpv] is a valuable tool for researchers investigating mesothelin-related diseases. Its use in diagnostic and therapeutic research can lead to significant advancements in the understanding and treatment of mesothelioma and ovarian cancer. By using this protein, researchers can:

• Enhance Diagnostic Accuracy: Improve the accuracy of mesothelin-based diagnostic tests.
• Advance Therapeutic Research: Support the development of new treatments for mesothelin-related cancers.

With its reliable performance and broad applicability, the Cynomolgus MSLN/Mesothelin Protein is an essential component of any research facility focused on oncology and related fields.